Perspective: Targeting the JAK/STAT pathway to fight age-related dysfunction

Ming Xu, Tamar Tchkonia, James L Kirkland

Research output: Contribution to journalReview article

13 Citations (Scopus)

Abstract

Senescent cells accumulate in a variety of tissues with aging. They can develop a senescence-associated secretory phenotype (SASP) that entails secretion of inflammatory cytokines, chemokines, proteases, and growth factors. These SASP components can alter the microenvironment within tissues and affect the function of neighboring cells, which can eventually lead to local and systemic dysfunction. The JAK pathway is more highly activate in senescent than non-senescent cells. Inhibition of the JAK pathway suppresses the SASP in senescent cells and alleviates age-related tissue dysfunction. Targeting senescent cells could be a promising way to improve healthspan in aged population.

Original languageEnglish (US)
Pages (from-to)152-154
Number of pages3
JournalPharmacological Research
Volume111
DOIs
StatePublished - Sep 1 2016

Fingerprint

Phenotype
Secretory Component
Chemokines
Intercellular Signaling Peptides and Proteins
Peptide Hydrolases
Cytokines
Population

Keywords

  • Cellular senescence
  • Frailty
  • Insulin resistance
  • Senolytics

ASJC Scopus subject areas

  • Pharmacology

Cite this

Perspective : Targeting the JAK/STAT pathway to fight age-related dysfunction. / Xu, Ming; Tchkonia, Tamar; Kirkland, James L.

In: Pharmacological Research, Vol. 111, 01.09.2016, p. 152-154.

Research output: Contribution to journalReview article

@article{a7dae1649a4d406d9f4cbed752160080,
title = "Perspective: Targeting the JAK/STAT pathway to fight age-related dysfunction",
abstract = "Senescent cells accumulate in a variety of tissues with aging. They can develop a senescence-associated secretory phenotype (SASP) that entails secretion of inflammatory cytokines, chemokines, proteases, and growth factors. These SASP components can alter the microenvironment within tissues and affect the function of neighboring cells, which can eventually lead to local and systemic dysfunction. The JAK pathway is more highly activate in senescent than non-senescent cells. Inhibition of the JAK pathway suppresses the SASP in senescent cells and alleviates age-related tissue dysfunction. Targeting senescent cells could be a promising way to improve healthspan in aged population.",
keywords = "Cellular senescence, Frailty, Insulin resistance, Senolytics",
author = "Ming Xu and Tamar Tchkonia and Kirkland, {James L}",
year = "2016",
month = "9",
day = "1",
doi = "10.1016/j.phrs.2016.05.015",
language = "English (US)",
volume = "111",
pages = "152--154",
journal = "Pharmacological Research",
issn = "1043-6618",
publisher = "Academic Press Inc.",

}

TY - JOUR

T1 - Perspective

T2 - Targeting the JAK/STAT pathway to fight age-related dysfunction

AU - Xu, Ming

AU - Tchkonia, Tamar

AU - Kirkland, James L

PY - 2016/9/1

Y1 - 2016/9/1

N2 - Senescent cells accumulate in a variety of tissues with aging. They can develop a senescence-associated secretory phenotype (SASP) that entails secretion of inflammatory cytokines, chemokines, proteases, and growth factors. These SASP components can alter the microenvironment within tissues and affect the function of neighboring cells, which can eventually lead to local and systemic dysfunction. The JAK pathway is more highly activate in senescent than non-senescent cells. Inhibition of the JAK pathway suppresses the SASP in senescent cells and alleviates age-related tissue dysfunction. Targeting senescent cells could be a promising way to improve healthspan in aged population.

AB - Senescent cells accumulate in a variety of tissues with aging. They can develop a senescence-associated secretory phenotype (SASP) that entails secretion of inflammatory cytokines, chemokines, proteases, and growth factors. These SASP components can alter the microenvironment within tissues and affect the function of neighboring cells, which can eventually lead to local and systemic dysfunction. The JAK pathway is more highly activate in senescent than non-senescent cells. Inhibition of the JAK pathway suppresses the SASP in senescent cells and alleviates age-related tissue dysfunction. Targeting senescent cells could be a promising way to improve healthspan in aged population.

KW - Cellular senescence

KW - Frailty

KW - Insulin resistance

KW - Senolytics

UR - http://www.scopus.com/inward/record.url?scp=84975840886&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84975840886&partnerID=8YFLogxK

U2 - 10.1016/j.phrs.2016.05.015

DO - 10.1016/j.phrs.2016.05.015

M3 - Review article

C2 - 27241018

AN - SCOPUS:84975840886

VL - 111

SP - 152

EP - 154

JO - Pharmacological Research

JF - Pharmacological Research

SN - 1043-6618

ER -